Pro- and anti-tumour activities of CD146/MCAM in breast cancer result from its heterogeneous expression and association with epithelial to mesenchymal transition
A. J. Mannion, A. F. Odell, S. M. Baker, L. C. Matthews, P. F. Jones, G. P. Cook
This study shows CD146/MCAM has both pro- and anti-tumour roles in breast cancer due to its heterogeneous expression and link to epithelial to mesenchymal transition.
Frontiers in Cell and Developmental Biology · Apr 17, 2023Peer-reviewedCancer Biology